छोड़कर सामग्री पर जाएँ

Latest News

Buy Federal Bank; target of Rs 170: Motilal Oswal

Buy Federal Bank; target of Rs 170: Motilal Oswal

Motilal Oswal is bullish on Federal Bank recommended buy rating on the stock with a target price of Rs 170 in its research report dated January 16, 2023.

Read More

​ Motilal Oswal is bullish on Federal Bank recommended buy rating on the stock with a target price of Rs 170 in its research report dated January 16, 2023. Motilal Oswal is bullish on Federal Bank recommended buy rating on the stock with a target price of Rs 170 in its research report dated January 16, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Federal Bank recommended buy rating on the stock with a target price of Rs 170 in its research report dated January 16, 2023.

Davos 2023: Ukraine first lady Olena Zelenska headlines first big day at meeting

Davos 2023: Ukraine first lady Olena Zelenska headlines first big day at meeting

The COVID-19 pandemic torpedoed the snow-covered event each of the last two years, but a springtime iteration was held eight months ago.

Read More

​ The COVID-19 pandemic torpedoed the snow-covered event each of the last two years, but a springtime iteration was held eight months ago. The COVID-19 pandemic torpedoed the snow-covered event each of the last two years, but a springtime iteration was held eight months ago.  Moneycontrol Latest News Read More  

The COVID-19 pandemic torpedoed the snow-covered event each of the last two years, but a springtime iteration was held eight months ago.

Buy Larsen and Toubro Finance Holdings; target of Rs 120: Motilal Oswal

Buy Larsen and Toubro Finance Holdings; target of Rs 120: Motilal Oswal

Motilal Oswal is bullish on Larsen and Toubro Finance Holdings recommended buy rating on the stock with a target price of Rs 120 in its research report dated January 16, 2023.

Read More

​ Motilal Oswal is bullish on Larsen and Toubro Finance Holdings recommended buy rating on the stock with a target price of Rs 120 in its research report dated January 16, 2023. Motilal Oswal is bullish on Larsen and Toubro Finance Holdings recommended buy rating on the stock with a target price of Rs 120 in its research report dated January 16, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Larsen and Toubro Finance Holdings recommended buy rating on the stock with a target price of Rs 120 in its research report dated January 16, 2023.

Metro Brands shares decline after shrink in Q3 operating profit margin

Metro Brands shares decline after shrink in Q3 operating profit margin

Metro Brands has announced an interim dividend of Rs 2.5 per share for the current financial year.

Read More

​ Metro Brands has announced an interim dividend of Rs 2.5 per share for the current financial year. Metro Brands has announced an interim dividend of Rs 2.5 per share for the current financial year.  Moneycontrol Latest News Read More  

Metro Brands has announced an interim dividend of Rs 2.5 per share for the current financial year.

Buy Just Dial; target of Rs 760: ICICI Direct

Buy Just Dial; target of Rs 760: ICICI Direct

ICICI Direct is bullish on Just Dial recommended buy rating on the stock with a target price of Rs 760 in its research report dated January 17, 2023.

Read More

​ ICICI Direct is bullish on Just Dial recommended buy rating on the stock with a target price of Rs 760 in its research report dated January 17, 2023. ICICI Direct is bullish on Just Dial recommended buy rating on the stock with a target price of Rs 760 in its research report dated January 17, 2023.  Moneycontrol Latest News Read More  

ICICI Direct is bullish on Just Dial recommended buy rating on the stock with a target price of Rs 760 in its research report dated January 17, 2023.

Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang

Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang

Net Sales are expected to increase by 14.1 percent Y-o-Y (up 4.8 percent Q-o-Q) to Rs 24,020 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 14.1 percent Y-o-Y (up 4.8 percent Q-o-Q) to Rs 24,020 crore, according to Nirmal Bang. Net Sales are expected to increase by 14.1 percent Y-o-Y (up 4.8 percent Q-o-Q) to Rs 24,020 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 14.1 percent Y-o-Y (up 4.8 percent Q-o-Q) to Rs 24,020 crore, according to Nirmal Bang.

Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang

Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang

Net Sales are expected to increase by 37 percent Y-o-Y (down 1.2 percent Q-o-Q) to Rs 4,549 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 37 percent Y-o-Y (down 1.2 percent Q-o-Q) to Rs 4,549 crore, according to Nirmal Bang. Net Sales are expected to increase by 37 percent Y-o-Y (down 1.2 percent Q-o-Q) to Rs 4,549 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 37 percent Y-o-Y (down 1.2 percent Q-o-Q) to Rs 4,549 crore, according to Nirmal Bang.

India making big strides in ease of doing business: DPIIT Secretary Anurag Jain

India making big strides in ease of doing business: DPIIT Secretary Anurag Jain

The Department for Promotion of Industry and Internal Trade (DPIIT) Secretary said several other steps are underway on further improving ease of doing business in India, including on the labour laws front.

Read More

​ The Department for Promotion of Industry and Internal Trade (DPIIT) Secretary said several other steps are underway on further improving ease of doing business in India, including on the labour laws front. The Department for Promotion of Industry and Internal Trade (DPIIT) Secretary said several other steps are underway on further improving ease of doing business in India, including on the labour laws front.  Moneycontrol Latest News Read More  

The Department for Promotion of Industry and Internal Trade (DPIIT) Secretary said several other steps are underway on further improving ease of doing business in India, including on the labour laws front.

Glenmark launches drug to treat heat failure

Glenmark launches drug to treat heat failure

The prescription drug has been launched under brand #39;Sacu V#39; and is priced at Rs 19 per tablet for a dose of 50mg (sacubitril 24mg valsartan 26mg), Rs 35 per tablet for a dose of 100mg (sacubitril 49mg valsartan 51mg), and Rs 45 per tablet for a dose of 200mg (sacubitril 97mg valsartan 103 mg), Glenmark said in a regulatory filing.

Read More

​ The prescription drug has been launched under brand #39;Sacu V#39; and is priced at Rs 19 per tablet for a dose of 50mg (sacubitril 24mg valsartan 26mg), Rs 35 per tablet for a dose of 100mg (sacubitril 49mg valsartan 51mg), and Rs 45 per tablet for a dose of 200mg (sacubitril 97mg valsartan 103 mg), Glenmark said in a regulatory filing. The prescription drug has been launched under brand #39;Sacu V#39; and is priced at Rs 19 per tablet for a dose of 50mg (sacubitril 24mg valsartan 26mg), Rs 35 per tablet for a dose of 100mg (sacubitril 49mg valsartan 51mg), and Rs 45 per tablet for a dose of 200mg (sacubitril 97mg valsartan 103 mg), Glenmark said in a regulatory filing.  Moneycontrol Latest News Read More  

The prescription drug has been launched under brand #39;Sacu V#39; and is priced at Rs 19 per tablet for a dose of 50mg (sacubitril 24mg valsartan 26mg), Rs 35 per tablet for a dose of 100mg (sacubitril 49mg valsartan 51mg), and Rs 45 per tablet for a dose of 200mg (sacubitril 97mg valsartan 103 mg), Glenmark said in a regulatory filing.

Glenmark launches drug to treat heat failure

Glenmark launches drug to treat heat failure

The prescription drug has been launched under brand #39;Sacu V#39; and is priced at Rs 19 per tablet for a dose of 50mg (sacubitril 24mg valsartan 26mg), Rs 35 per tablet for a dose of 100mg (sacubitril 49mg valsartan 51mg), and Rs 45 per tablet for a dose of 200mg (sacubitril 97mg valsartan 103 mg), Glenmark said in a regulatory filing.

Read More

​ The prescription drug has been launched under brand #39;Sacu V#39; and is priced at Rs 19 per tablet for a dose of 50mg (sacubitril 24mg valsartan 26mg), Rs 35 per tablet for a dose of 100mg (sacubitril 49mg valsartan 51mg), and Rs 45 per tablet for a dose of 200mg (sacubitril 97mg valsartan 103 mg), Glenmark said in a regulatory filing. The prescription drug has been launched under brand #39;Sacu V#39; and is priced at Rs 19 per tablet for a dose of 50mg (sacubitril 24mg valsartan 26mg), Rs 35 per tablet for a dose of 100mg (sacubitril 49mg valsartan 51mg), and Rs 45 per tablet for a dose of 200mg (sacubitril 97mg valsartan 103 mg), Glenmark said in a regulatory filing.  Moneycontrol Latest News Read More  

The prescription drug has been launched under brand #39;Sacu V#39; and is priced at Rs 19 per tablet for a dose of 50mg (sacubitril 24mg valsartan 26mg), Rs 35 per tablet for a dose of 100mg (sacubitril 49mg valsartan 51mg), and Rs 45 per tablet for a dose of 200mg (sacubitril 97mg valsartan 103 mg), Glenmark said in a regulatory filing.

hi_INहिन्दी